Global Tumor Ablation Market by Type, Application, Deployment, Key Customers, Offerings, Vertical and Geographic Till 2025

The Report Titled Tumor Ablation Market Brings an Analytical view of the Tumor Ablation performance in the global as well as the regional scenario. In a detailed chapter-wise format, the Tumor Ablation study figure out various aspects corresponding to the international and local Tumor Ablation market. To start with, the Tumor Ablation Market definition, applications, classification, and Tumor Ablation industry value chain structure are included in the report, to update target audience on binding Tumor Ablation dynamics including drivers, restraints, threats, opportunities, trends, applications, geographical/regional Automotive Adhesives, and competitive landscape.

To Get A Free Sample @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-tumour-ablation-market

Scope of the Report:
  • The global tumor ablation market is segmented on the basis of type, cancer type, mode of treatment, end user, and geography.
  • On the basis of Type, the market is segmented into three major segments which include tumor ablation systems, image guidance products, and accessories. In 2017, the Tumor Ablation Systems market segment is expected to dominate the market with 69.2%. Tumor Ablation Systems is further sub segmented into radio frequency ablation system (RFA), microwave ablation system, cryoablation, high intensity focused ultrasound and laser ablation system. In 2017, radio frequency ablation system (RFA) market segment is expected to dominate the market with 53.8%.
  • On the basis of Cancer Type, the market is segmented into eight major segments which include liver cancer, brain cancer, lung cancer, bone cancer, kidney cancer, pancreatic cancer, breast cancer and others, The lung cancer market is expected to grow at the highest CAGR 10.7% in the forecast period of 2017 to 2024.
  • On the basis of Mode Of Treatment, the global Tumor Ablation Market is segmented into surgical, laproscopic and percutaneous. The Surgical is projected to witness higher growth during the forecast period., The laparoscopic market is expected to grow at the highest CAGR 10.8% in the forecast period of 2017 to 2024.
  • On the basis of End-users, the market is segmented into hospital, oncology clinics, and others. In 2017, the hospital market segment is expected to dominate the market. with a share of 68.3%.
  • On the basis of Geography, the market is segmented into 5 geographical regions,
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa.

Have Any Query? Speak To Our Expert @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-tumour-ablation-market

Key Points of Global Tumor Ablation Market:
  • In 2017, the tumor ablation systems segment is expected to account for the largest share of 69.2% of the global tumor ablation market, by type. This segment is expected to grow at the highest CAGR of 10.2% in the forecast period 2017 to 2024.
  • Radio frequency ablation system segment is going to dominate the tumor ablation market owing to effective treatment for small cancers, minimal risk to patient, and faster results will drive the growth of the market.
Key Players/Vendors:
  • Galil Medical, Inc.,
  • Perseon Corporation,
  • NeuWave Medical, Inc.,
  • Koninklijke Philips N.V.,
  • INTIO Inc.,
  • Mermaid Medical A/S,
  • SonaCare Medical, LLC,
  • DFINE, Inc.,
  • Misonix, Inc.,
  • BVM Medical Limited,
  • AngioDynamics, Inc.,
  • COMSOL Inc.,
  • Boston Scientific Corporation,
  • EDAP TMS S.A.
  • HealthTronics, Inc.
Major Factors:
Some of the major factors driving the market for global tumor ablation market are increasing incidences of cancer patients, increase in the number of hospitals, ablation and surgical centers, technological advancement in ablation devices. These factors increase the demand for devices such as tumor ablation systems and image guidance products.
  • High treatment cost and side effects associated with ablation treatment may hinder the growth of this market.
  • According to American Cancer Society, in 2017, approximately 1,688,780 new cancer cases were diagnosed and 600,920 cancer deaths were reported in the US.
  • Many companies are increasingly focusing on technological advancement of devices in order to strengthen their product portfolios in the tumor ablation market.

Key Topics Mentioned:
  1. INTRODUCTION
1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION
1.3. MARKET SCOPE
1.4. OVERVIEW OF GLOBAL TUMOR ABLATION MARKET
1.5. CURRENCY AND PRICING
1.6. LIMITATION
1.7. MARKETS COVERED
  1. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCE
2.8. ASSUMPTIONS
  1. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. INCREASING PREVALENCE OF CANCER PATIENTS
3.1.2. TECHNOLOGICAL ADVANCEMENTS IN ABLATION DEVICES
3.1.3. RISING NUMBER OF HOSPITALS, SURGICAL, AND ABLATION CENTERS
3.2. RESTRAINTS
3.2.1. HIGH COST OF TUMOR ABLATION TREATMENT
3.2.2. SIDE EFFECTS ASSOCIATED WITH ABLATION TREATMENT
3.2.3. SHORTAGE OF SKILLED AND TRAINED PROFESSIONALS
3.3. OPPORTUNITIES
3.3.1. GROWTH POTENTIAL OFFERED BY DEVELOPING MARKETS
3.3.2. GROWING AWARENESS ABOUT ABLATION PROCEDURES
3.4. CHALLENGES
3.4.1. STRINGENT REGULATORY GUIDELINES
  1. EXECUTIVE SUMMARY
  2. PREMIUM INSIGHTS
  3. GLOBAL TUMOR ABLATION MARKET, BY TYPE
6.1. OVERVIEW
6.2. TUMOR ABLATION SYSTEMS
6.2.1. RADIOFREQUENCY ABLATION SYSTEM (RFA)
6.2.2. MICROWAVE ABLATION SYSTEM
6.2.3. HIGH FREQUENCY FOCUSED ULTRASOUND ABLATION SYSTEM (HIFU)
6.2.4. LASER ABLATION SYSTEM
6.2.5. CRYOABLATION
6.3. IMAGE GUIDANCE PRODUCTS
6.4. ACCESSORIES
  1. GLOBAL TUMOR ABLATION MARKET, BY CANCER TYPE
7.1. OVERVIEW
7.2. LIVER CANCER
7.3. BRAIN CANCER
7.4. LUNG CANCER
7.5. BONE CANCER
7.6. KIDNEY CANCER
7.7. PANCREATIC CANCER
7.8. BREAST CANCER
7.9. OTHERS
  1. GLOBAL TUMOR ABLATION MARKET, BY MODE OF TREATMENT
8.1. OVERVIEW
8.2. SURGICAL
8.3. LAPAROSCOPIC
8.4. PERCUTANEOUS
  1. GLOBAL TUMOR ABLATION MARKET, BY END USER
9.1. OVERVIEW
9.2. HOSPITALS
9.3. ONCOLOGY CLINICS
9.4. OTHERS
  1. GLOBAL TUMOR ABLATION MARKET, BY GEOGRAPHY
10.1. OVERVIEW
10.2. NORTH AMERICA
10.3. EUROPE
10.4. ASIA-PACIFIC
10.5. SOUTH AMERICA
10.6. MIDDLE EAST AND AFRICA
  1. GLOBAL TUMOR ABLATION MARKET, COMPANY LANDSCAPE
11.1. COMPANY SHARE ANALYSIS: GLOBAL
11.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3. COMPANY SHARE ANALYSIS: EUROPE
11.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC
  1. COMPANY PROFILES
1.1. MEDTRONIC
1.1.1. COMPANY OVERVIEW
1.1.2. MEDTRONIC :REVENUE ANALYSIS
1.1.3. PRODUCT PORTFOLIO
1.1.4. RECENT DEVELOPMENTS
1.2. STRYKER
1.2.1. COMPANY OVERVIEW
1.2.2. STRYKER :REVENUE ANALYSIS
1.2.3. PRODUCT PORTFOLIO
1.2.4. RECENT DEVELOPMENTS
1.3. TERUMO CORPORATION
1.3.1. COMPANY OVERVIEW
1.3.2. TERUMO CORPORATION :REVENUE ANALYSIS
1.3.3. PRODUCT PORTFOLIO
1.3.4. RECENT DEVELOPMENTS
1.4. INTEGRA LIFESCIENCES CORPORATION
1.4.1. COMPANY OVERVIEW
1.4.2. INTEGRA LIFESCIENCES CORPORATION : REVENUE ANALYSIS
1.4.3. PRODUCT PORTFOLIO
1.4.4. RECENT DEVELOPMENTS
1.5. KONINKLIJKE PHILIPS N.V.
1.5.1. COMPANY OVERVIEW
1.5.2. KONINKLIJKE PHILIPS N.V.: REVENUE ANALYSIS
1.5.3. PRODUCT PORTFOLIO
1.5.4. RECENT DEVELOPMENTS
1.6. NEUWAVE MEDICAL, INC (ACQUIRED BY ETHICON US, LLC, SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
1.6.1. COMPANY OVERVIEW
1.6.2. JOHNSON & JOHNSON SERVICES, INC.:REVENUE ANALYSIS
1.6.3. PRODUCT PORTFOLIO
1.6.4. RECENT DEVELOPMENTS
1.7. BOSTON SCIENTIFIC CORPORATION
1.7.1. COMPANY OVERVIEW
1.7.2. BOSTON SCIENTIFIC CORPORATION :REVENUE ANALYSIS
1.7.3. PRODUCT PORTFOLIO
17.4. RECENT DEVELOPMENTS
1.8. MERMAID MEDICAL A/S
1.8.1. COMPANY OVERVIEW
1.8.2. MERMAID MEDICAL A/S: COMPANY SNAPSHOT
1.8.3. PRODUCT PORTFOLIO
1.8.4. RECENT DEVELOPMENTS
1.9. SONACARE MEDICAL, LLC
1.9.1. COMPANY OVERVIEW
1.9.2. SONACARE MEDICAL, LLC.: COMPANY SNAPSHOT
1.9.3. PRODUCT PORTFOLIO
1.9.4. RECENT DEVELOPMENTS
1.10. MERIT MEDICAL SYSTEMS, INC
1.10.1. COMPANY OVERVIEW
1.10.2. MERIT MEDICAL SYSTEMS, INC.:REVENUE ANALYSIS
1.10.3. PRODUCT PORTFOLIO
1.10.4. RECENT DEVELOPMENTS
1.11. BVM MEDICAL LIMITED
1.11.1. COMPANY OVERVIEW
1.11.2. BVM MEDICAL LIMITED : COMPANY SNAPSHOT
1.11.3. PRODUCT PORTFOLIO
1.11.4. RECENT DEVELOPMENTS
1.12. INSIGHTEC LTD
1.12.1. COMPANY OVERVIEW
1.12.2. INSIGHTEC LTD :COMPANY SNAPSHOT
1.12.3. PRODUCT PORTFOLIO
1.12.4. RECENT DEVELOPMENTS
1.13. ABBOTT
1.13.1. COMPANY OVERVIEW
1.13.2. ABBOTT:REVENUE ANALYSIS
1.13.3. PRODUCT PORTFOLIO
1.13.4. RECENT DEVELOPMENTS
1.14. VYTRONUS, INC
1.14.1. COMPANY OVERVIEW
1.14.2. VYTRONUS, INC : COMPANY SNAPSHOT
1.14.3. PRODUCT PORTFOLIO
1.14.4. RECENT DEVELOPMENTS
1.15. BALYIS MEDICAL
1.15.1. COMPANY OVERVIEW
1.15.2. BAYLIS MEDICAL : COMPANY SNAPSHOT
1.15.3. PRODUCT PORTFOLIO
1.15.4. RECENT DEVELOPMENTS
1.16. EDAP TMS
1.16.1. COMPANY OVERVIEW
1.16.2. REVENUE ANALYSIS
1.16.3. PRODUCT PORTFOLIO
1.16.4. RECENT DEVELOPMENTS
1.17. ATRICURE, INC.
1.17.1. COMPANY OVERVIEW
1.17.2. REVENUE ANALYSIS
1.17.3. PRODUCT PORTFOLIO
1.17.4. RECENT DEVELOPMENTS
1.18. FCARE SYSTEMS
1.18.1. COMPANY OVERVIEW
1.18.2. FCARE SYSTEMS: COMPANY SNAPSHOT
1.18.3. PRODUCT PORTFOLIO
1.18.4. RECENT DEVELOPMENTS
1.19. ECO, INC.
1.19.1. COMPANY OVERVIEW
1.19.2. ECO INC. : COMPANY SNAPSHOT
1.19.3. PRODUCT PORTFOLIO
1.19.4. RECENT DEVELOPMENTS
1.20. NONINVASIVE MEDICAL DEVICES, LTD.
1.20.1. COMPANY OVERVIEW
1.20.2. NONINVASIVE MEDICAL DEVICES, LT. : COMPANY SNAPSHOT
1.20.3. PRODUCT PORTFOLIO
1.20.4. RECENT DEVELOPMENTS
  1. RELATED REPORTS

To view Full Report @ http://databridgemarketresearch.com/reports/global-tumour-ablation-market/

Related Report
Global Intra-Uterine Contraceptive Devices Market – Industry Trends and Forecast to 2024
Global Intra-Uterine Contraceptive Devices, By Product Type (Hormonal IUCD, Copper IUCD), By End-User (Hospitals, Gynecology Clinics, Community Healthcare), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) –Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-intra-uterine-contraceptive-devices-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

Comments

Post a Comment

Popular posts from this blog

Global NGS Services Market - Industry Trends and Forecast to 2025

Image
Global NGS Services Market By Technique (Nanopore Seq, Ion Semiconductor Seq, Single-Molecule RT Sequencing, Sequencing By Synthesis), Service (RNA-Seq, De Novo Seq, Exome Sequencing, Targeted Resequencing Gene Panels, Chip-Seq, Whole-Genome Seq, Methyl-Seq), Application (Drug Discovery, Biomarker Discovery, Diagnostics, Agriculture & Animal Research), End-User, Geography – Industry Trends and Forecast to 2025 For In depth Information Get Free Sample Copy of this Report@ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-ngs-services-market Top Key Holders: BGI GATC Biotech AG Illumina, Inc. Genotypic Technology Pvt Ltd QIAGEN, Macrogen, Inc. Eurofins Scientific PerkinElmer Inc. Personalis Inc. Novogene Corporation SciGenom Labs Pvt. Ltd TAKARA HOLDINGS INC. Kohlberg Kravis Roberts & Co. P.GENEWIZ Agilent Technologies Genomatix GmbH Pacific Biosciences of California, Inc. Hoffmann-La Roche Ltd Thermo Fisher Scientific Inc. Biomatters L
Read more

Global Diabetes Drug Market - Industry Trends and Forecast to 2023

The Diabetes Drug Market Report deliver comprehensive analysis of the market structure along with forecast of the various segments and sub-segments of the Diabetes Drug Market. The Market report includes historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. The report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the Market. The scope of this Diabetes Drug Market report extends from market scenarios to comparative pricing between major players, cost and profit of the specified market regions. Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two type of diabetes namely type-1 diabetes and type-2 diabetes. During last decade there is a tremendous increase in the number of diabetic population.This report focuses on the Diabetes Drug in global market, especially in North America, Europe and Asi
Read more

Global Pulmonary Drug Delivery Market - Industry Trends and Forecast to 2025

Image
Global Pulmonary Drug Delivery Market , By Type (Dry Powder Inhalers, Nebulizers, Metered Dose Inhalers, Solution Aerosols, Suspension Aerosols), Application (Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis, Other Applications), End-User (Hospitals & Clinics, Home Care Settings), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, E-Commerce), Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024. Request for Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-pulmonary-drug-delivery-market Global Pulmonary Drug Delivery Market Key Drivers: Technological Advancement Growing Incidence of Respiratory Diseases Rising Focus on the Expansion of Smart/Digital Inhalers Regulatory Concerns Stability Issues With The Products Request for Detailed TOC : http://databridgemarketresearch.com/toc/?dbmr=global-pulmonary-drug-delivery-market
Read more